Exhale

The official blog of the Lung Institute.

Do I Have COPD? 6 Factors that Should Prompt a COPD Test

20 Feb 2018
| Under COPD, Lung Disease | Posted by | 0 Comments
6 Factors that Should Prompt a COPD Test

The American Lung Association shares that in the United States chronic obstructive pulmonary disease (COPD)—a lung disease that makes it difficult to breathe—is the third leading cause of death. Sadly, although 11 million Americans have received a COPD diagnosis, the American Lung Association says that “millions more may have the disease without knowing it.” So,…

Read More >

3 Soups Good for Your Tummy AND Your COPD

15 Feb 2018
| Under COPD, Diet and Nutrition | Posted by | 2 Comments
3-Soups-Good-for-Your-Tummy

When it’s cold outside, nothing tastes better than a steaming-hot bowl of your favorite soup. But what many people don’t realize is that, oftentimes, the ingredients in your soup of choice can help protect you from the latest bug. This is especially important if you suffer from chronic obstructive pulmonary disease (COPD) as research has…

Read More >

What is My Why? Michelle Lesser

14 Feb 2018
| Under Featured | Posted by | 0 Comments
What is My Why? Michelle Lesser

A featured series where Lung Institute employees tell their stories. #WhatIsMyWhy I have been with the Lung Institute for three years. I truly believe in what we do, and I also have a passion for what we do. I am the community relations specialist and in my role, I act as a physician’s liaison going…

Read More >

Valentine’s Day Gifts for Those with Lung Disease and Their Caregivers

13 Feb 2018
| Under Caregiver, Lung Disease | Posted by | 0 Comments
Valentine’s Day Gifts for Those with Lung Disease and Their Caregivers

Valentine’s Day is a day of love. It’s a day dedicated to showing the people in our lives how much we appreciate them. That we care for them. That our world is a much better place solely because they’re in it. One way we do this is by giving them Valentine’s Day gifts. Gift Ideas…

Read More >

What is My Why? Loribeth Valdez

7 Feb 2018
| Under Featured | Posted by | 2 Comments
What is My Why? Loribeth Valdez

: I do think I have a good ear and a sympathetic feel for what our patients experience. Some patients are angry about their situation. Many don’t realize there is something they can do to feel better. I want them to give up their anger, see hope and not give up.

Read More >

Lung Institute’s Dr. Jack Coleman Featured on CareDash.com

1 Feb 2018
| Under Featured | Posted by | 2 Comments
Lung Institute’s Dr. Jack Coleman Featured on CareDash.com

When CareDash.com, a leading patient-advocacy website, wanted an expert to talk about the disease, they turned to the Lung Institute’s senior medical director, Dr. Jack Coleman.

Read More >

What is My Why? Melissa Rubio

31 Jan 2018
| Under Featured | Posted by | 0 Comments
What Is My Why_Melissa

I was drawn to the Lung Institute for various reasons. First, lung health is extremely important to me and second, I am able to see the difference our treatment can make for those with chronic lung disease.

Read More >

The Lung Institute earns The Joint Commission’s Gold Seal of Approval

30 Jan 2018
| Under Featured | Posted by | 8 Comments
The Lung Institute earns The Joint Commission's Gold Seal of Approval

We, at the Lung Institute, are proud to announce we have earned The Joint Commission’s Gold Seal of Approval® for Ambulatory Health Care Accreditation. This prestigious accreditation is given to organizations that demonstrate continuous compliance with The Joint Commission’s nationally recognized standards. The Gold Seal of Approval® is a symbol of high quality that reflects…

Read More >

Lung Institute Nationally Recognized by the Joint Commission and Awarded Ambulatory Health Care Accreditation

| Under Press | Posted by | 2 Comments

Tampa, Florida, Jan. 30, 2018 – Lung Institute, a provider of stem cell treatment therapy to patients with developing or developed COPD and under the medical management company Regenerative Medicine Solutions, today announced it has earned The Joint Commission’s Gold Seal of Approval® for Ambulatory Health Care Accreditation by demonstrating continuous compliance with its nationally recognized…

Read More >

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.